John T Mullen
Affiliation: Harvard University
- Viral oncolysisJohn T Mullen
Division of Surgical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114-2696, USA
Oncologist 7:106-19. 2002..Special attention is focused on the unique biology of each of these viruses as well as the status of several of these mutants in clinical trials...
- Viral oncolysisJames M Donahue
Massachusetts General Hospital, Harvard Medical School, Cox 626, 100 Blossom Street, Boston, MA 02114-2696, USA
Surg Oncol Clin N Am 11:661-80. 2002..In addition, using similar genetic modification strategies, these viruses have demonstrated antineoplastic effects in humans similar to those seen in preclinical animal models...
- Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgeryJohn T Mullen
Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Stoneman 912, Boston, MA 02215, USA
Ann Surg Oncol 15:2164-72. 2008..Obesity is an increasingly common serious chronic health condition. We sought to determine the impact of body mass index (BMI) on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery...
- The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgeryJohn T Mullen
Department of Surgery, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Stoneman 912, Boston, MA 02215, USA
Ann Surg 250:166-72. 2009..We sought to examine the effect of body mass index (BMI) on 30-day morbidity and mortality in a large cohort of patients undergoing nonbariatric general surgery...
- Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastasesDaria Zorzi
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
J Gastrointest Surg 10:86-94. 2006..AR is not superior to WR in terms of tumor clearance, pattern of recurrence, or survival. WR should remain an integral component of the surgical treatment of CLM...
- Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomyJohn T Mullen
Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Am Coll Surg 204:854-62; discussion 862-4. 2007..No standard definition of PHI has been established, but one is essential for meaningful comparison of outcomes data across studies...
- Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun
Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston, TX 77030, USA
J Gastrointest Surg 11:1498-504; discussion 1504-5. 2007..The aim of this study was to compare the outcome of patients with CLM treated with preoperative chemotherapy followed by one- or two-stage hepatectomy...